MLTXMoonLake Immunotherapeutics
$11.87+27% 1Y
$11.87
$9.1252 weeks$22.16
Is the business good?
How good a business is MLTX?
- Share count, year on year
- +17%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$225M
- Net income, trailing twelve months
- −$264M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.